# GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia

> **NCT07372885** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Manchester** · enrollment: 50 (estimated)

## Conditions studied

- Acute Myeloid Leukemia
- Stem Cell Transplantation
- Stem Cell Transplantation, Hematopoietic
- Cord Blood Stem Cell Transplantation
- Cellular Therapy

## Interventions

- **BIOLOGICAL:** Cord blood transplantation + conditioning + granulocytes of variable days according to study design

## Key facts

- **NCT ID:** NCT07372885
- **Lead sponsor:** University of Manchester
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-09
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-03-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07372885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07372885, "GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07372885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*